T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Avery Dennison
AVY
$13.6B
| $18M | ﹤0.01% |
156,682
+254
| +0.2% | +$27.5K |
|
|
DRE
1227
DELISTED
Duke Realty Corp.
DRE
| $17.9M | ﹤0.01% |
659,104
-3,600
| -0.5% | -$102K |
|
1228
Teck Resources
TECK
$32.4B
| $17.8M | ﹤0.01% |
681,960
+665,760
| +4,110% | +$15.2M |
|
|
IRCP
1229
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
| $17.8M | ﹤0.01% |
1,349,432
+651,430
| +93% | +$8.73M |
|
|
WDR
1230
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $17.7M | ﹤0.01% |
793,641
-335,473
| -30% | -$6.83M |
|
1231
Zions Bancorporation
ZION
$10.5B
| $17.7M | ﹤0.01% |
348,178
+1,170
| +0.3% | +$56K |
|
1232
World Kinect Corp
WKC
$1.89B
| $17.5M | ﹤0.01% |
623,132
-1,955
| -0.3% | -$59K |
|
1233
Pinnacle West Capital
PNW
$12.2B
| $17.4M | ﹤0.01% |
204,712
+610
| +0.3% | +$53.9K |
|
1234
Diageo
DEO
$52.8B
| $17.2M | ﹤0.01% |
117,843
-8,201
| -7% | -$1.13M |
|
1235
Leidos
LDOS
$17.6B
| $17M | ﹤0.01% |
262,874
-1,072
| -0.4% | -$67.2K |
|
|
LABL
1236
DELISTED
Multi-Color Corp
LABL
| $16.9M | ﹤0.01% |
226,304
+2,110
| +0.9% | +$164K |
|
|
KS
1237
DELISTED
KapStone Paper and Pack Corp.
KS
| $16.9M | ﹤0.01% |
746,527
-7,710
| -1% | -$170K |
|
1238
Team
TISI
$101M
| $16.9M | ﹤0.01% |
113,451
-42,741
| -27% | -$5.69M |
|
1239
Campbell Soup
CPB
$6.94B
| $16.9M | ﹤0.01% |
350,659
+1,600
| +0.5% | +$76K |
|
1240
Nu Skin
NUS
$236M
| $16.8M | ﹤0.01% |
246,404
+1,653
| +0.7% | +$107K |
|
|
MNTA
1241
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $16.7M | ﹤0.01% |
1,196,046
+391,760
| +49% | +$5.3M |
|
1242
OSI Systems
OSIS
$3.82B
| $16.7M | ﹤0.01% |
258,809
+2,329
| +0.9% | +$196K |
|
1243
Everest Group
EG
$13.9B
| $16.4M | ﹤0.01% |
74,179
+10
| +0% | +$2.25K |
|
1244
Boot Barn
BOOT
$4.87B
| $16.3M | ﹤0.01% |
983,677
-36,400
| -4% | -$436K |
|
1245
Toll Brothers
TOL
$13.9B
| $16.3M | ﹤0.01% |
340,126
+38,490
| +13% | +$1.77M |
|
|
SUPV
1246
Grupo Supervielle
SUPV
$725M
| $16.3M | ﹤0.01% |
555,640
-115,890
| -17% | -$3.08M |
|
|
BOJA
1247
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $16.2M | ﹤0.01% |
1,374,625
-1,776,022
| -56% | -$22.4M |
|
1248
Capri Holdings
CPRI
$1.77B
| $16.2M | ﹤0.01% |
256,625
-16,730
| -6% | -$917K |
|
|
ABLX
1249
DELISTED
Ablynx NV
ABLX
| $16M | ﹤0.01% |
+640,460
| New | +$14.5M |
|
1250
NETSCOUT
NTCT
$2.87B
| $16M | ﹤0.01% |
524,740
+12,882
| +3% | +$394K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.